Taoyuan, Taiwan

Wen-Hung Chung

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Academia Sinica, Chang Gung Medical Foundation, Chang Gung Medical Foundation Chang Gung Memorial Hospital at Keelung. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Hung Chung. Retrieved from https://idiyas.com/inventor/wen-hung-chung-p3apeg6f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Taipei, TW (2010)
  • Taoyuan County, TW (2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Wen-Hung Chung: Pioneering Research in Adverse Drug Reactions

Introduction

Wen-Hung Chung, an innovative inventor based in Taoyuan County, Taiwan, has made significant contributions to the field of pharmacogenetics and autoimmune disorders. With two patents to his name, he has developed advanced methodologies aimed at improving patient safety and treatment efficacy.

Latest Patents

Chung's latest patents include a groundbreaking method for risk assessment related to phenytoin-induced adverse drug reactions (ADRs). This innovation involves predicting patients' susceptibility to severe reactions such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reactions with eosinophilia and systemic symptoms (DRESS). By assessing specific genetic polymorphisms of CYP2C genes and HLA alleles, his invention provides a kit that helps healthcare professionals evaluate the risk of adverse reactions in patients treated with phenytoin-related drugs.

Another significant patent from Chung focuses on granulysin, which reveals novel applications in diagnosing and treating autoimmune disorders. This research holds promise for advancing our understanding and management of such complex health issues.

Career Highlights

Wen-Hung Chung has an impressive career with affiliations to prominent research institutions, including Academia Sinica and the Chang Gung Medical Foundation, Linkou Branch. His expertise in pharmacogenetics is recognized internationally, contributing to the advancement of personalized medicine and improving treatment outcomes for patients.

Collaborations

Throughout his career, Chung has collaborated with notable colleagues, including Shuen-Iu Hung and Yuan-Tsong Chen. These partnerships have helped advance his research and foster innovation in the medical field, demonstrating the value of teamwork in the pursuit of cutting-edge solutions.

Conclusion

Wen-Hung Chung exemplifies the spirit of innovation in his field. Through his patents and collaborative research efforts, he continues to make valuable contributions that enhance patient care and safety. His work not only addresses critical health challenges but also sets the groundwork for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…